Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis

dc.contributor.author	Medeiros, Cely Saad Abboud	pt_BR
dc.contributor.author	Rao, Gauri G.	pt_BR
dc.contributor.author	Souza, Ercilia Evangelista de	pt_BR
dc.contributor.author	Zavascki, Alexandre Prehn	pt_BR
dc.contributor.author	Kiffer, Carlos Roberto Veiga	pt_BR
dc.date.accessioned	2019-10-11T03:55:06Z	pt_BR
dc.date.issued	2018	pt_BR
dc.identifier.issn	1413-8670	pt_BR
dc.identifier.uri	http://hdl.handle.net/10183/200515	pt_BR
dc.description.abstract	A retrospective cohort study, were evaluated: polymyxin B plus aminoglycosides orpolymyxin B plus other antibiotics. Any degree of acute kidney injury occurred in 26 (86.6%)patients. The median time to acute kidney injury was 6.0 (95% CI 3–14) days in the polymyxin-aminoglycoside containing regimen group, against 27.0 (95% CI 6–42) days in the polymyxinwith other antimicrobial combinations group (p = 0.03). Polymyxin B with aminoglycosidesgroup progressed faster to any degree of renal dysfunction.	en
dc.format.mimetype	application/pdf	pt_BR
dc.language.iso	eng	pt_BR
dc.relation.ispartof	The Brazilian journal of infectious diseases. Salvador. vol. 22, no. 1 (Jan./Feb. 2018), p. 51-54	pt_BR
dc.rights	Open Access	en
dc.subject	Lesão renal aguda	pt_BR
dc.subject	Enterobacteriáceas resistentes a carbapenêmicos	pt_BR
dc.title	Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis	pt_BR
dc.type	Artigo de periódico	pt_BR
dc.identifier.nrb	001091520	pt_BR
dc.type.origin	Nacional	pt_BR

Este item está licenciado na Creative Commons License